Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.

Not Applicable

Recruiting

• Conditions: Lung Cancer
• Interventions: Device: Electrocautery; Device: Harmonic ACE23P Scalpel

• Registration Number: NCT00591552
• Lead Sponsor: Sentara Cardiovascular Research Institute

Brief Summary

In an effort to elucidate whether the Harmonic Scalpel will improve sealing lymphatics and decrease lymphatic drainage thereby decreasing the length of time that chest tubes are required and minimizing length of stay; the Harmonic Scalpel will be compared to a control group which uses electrocautery. This study will assess these two different methods to determine if there is a notable decrease in the amount of drainage with one versus the other.

Detailed Description

Lymph node dissection is an integral part of the surgical management of lung cancer. Knowledge of lymph node status plays a key role in therapeutic decision making and prognosis. Associated with this dissection comes the propensity for lymphatic leakage, increased chest tube drainage, prolonged retention of chest tubes in the postoperative period and increased patient length of stay. Our center performs complete mediastinal node dissection of all relevant regional lymph nodes which generally include paratracheal, pretracheal, subcarinal, hilar and paraesophageal nodes. The current standard of practice for the dissection of the lymph nodes includes the use of the Harmonic Scalpel or electrocautery. Known risk of electrocautery include localized nerve damage, cardiac arrhythmias and damage to the tissue sample/specimen that is used for pathology. The Harmonic Scalpel technology has recently become available for use. Current experience with the Harmonic Scalpel suggests that there is less localized nerve damage, less incidence of arrhythmias, less damage to the tissue sample and less lymph leakage. There is no published data to support this hypothesis, thus the purpose of this study.

Study Timeline

• Study Start: 2007-12
• Study First Submitted: 2007-12-26
• Study First Submitted QC: 2008-01-10
• Study First Posted: 2008-01-11
• Status Verified: 2023-11
• Last Update Submitted: 2023-11-20
• Last Update Posted: 2023-11-21
• Primary Completion: 2024-11
• Study Completion: 2024-11

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients undergoing resection for stage 1, 2 or 3A lung cancer.
• Patients between the ages of 20-75.

Exclusion Criteria

• History of Congestive Heart Failure.
• History of renal failure, ie., creatinine greater than 2.2.
• Patients with bulky or matted lymph nodes in stage 3A.
• Current pregnancy.
• Current participation in another study involving an investigational device or drug.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group A	Electrocautery	Electrocautery used for dissection.
Group B	Harmonic ACE23P Scalpel	Harmonic Scalpel used for dissection

Primary Outcome Measures

Name	Time	Method
Amount of chest tube drainage	daily

Secondary Outcome Measures

Name	Time	Method
Pleural effusions monitored by chest x-ray.	Every other day and at four weeks

Trial Locations

Locations (1)

Sentara Norfolk General Hospital/Sentara Heart Hospital; 🇺🇸 Norfolk, Virginia, United States